There are few preclinical studies of CRHR1 antagonists treating endometriosis and bladder disorders; therefore, additional studies must be done before these drugs reach clinical trials for these diseases such as the studies included in this review that demonstrated positive results [25,27,50]. Here, CRHR1 is linked to endometriosis.